Profitability Ratios
| Ratio |
Value |
| GP Margin |
98.3% |
| EBIT Margin |
-32.5% |
| EBITDA Margin |
-30.4% |
| Operating Margin |
-40.5% |
| Pretax Margin |
-40.3% |
| Cont. Ops Margin |
-40.4% |
| Net Margin |
-40.4% |
| Bottom Line Margin |
-40.4% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
3.83 |
| Quick Ratio |
3.81 |
| Solvency Ratio |
-0.119 |
| Cash Ratio |
0.48 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
1.53 |
| Forward PEG |
1.53 |
| Price/Book |
25.88 |
| Price/Sales |
13.41 |
| Price/FCF |
-39.55 |
| Price/Op Cash Flow |
-47.13 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.7419 |
| Debt/Equity |
5.3453 |
| Debt/Capital |
0.8424 |
| Long-Term Debt/Capital |
0.7952 |
| Financial Leverage |
7.20 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.42 |
| Operating Cash Flow Ratio |
-0.344 |
| Operating Cash Flow/Sales |
-28.5% |
| Free Cash Flow/Operating Cash Flow |
119.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-0.55 |
| Interest Coverage |
-5.2329 |
| Short-Term Operating Cash Flow Coverage |
-0.59 |
| Operating Cash Flow Coverage |
-0.10 |
| Capital Expenditure Coverage |
-5.22 |
| Dividend + Capital Expenditure Coverage |
-5.22 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
5.90 |
| EPS |
-2.381 |
| Debt/Share |
16.7958 |
| Cash/Share |
16.73 |
| Book Value/Share |
3.06 |
| Tangible BV/Share |
3.06 |
| Equity/Share |
3.06 |
| Operating Cash Flow/Share |
-1.679 |
| Capital Expenditure/Share |
0.322 |
| FCF/Share |
-2.000 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.003 |
| Earnings Before Tax/EBIT |
0.995 |
| Price/Fair Value |
25.88 |
| Debt/Market Cap |
0.1858 |
| Effective Tax Rate |
-0.3% |
| Enterprise Value Multiple |
-51.96 |
IONS - Ionis Pharmaceuticals, Inc.